Regorafenib mesylate
Regorafenib mesylate is an oral multi-target tyrosine kinase inhibitor with potent anti-tumor and anti-angiogenic activity. It effectively inhibits key oncogenic targets including VEGFR2, PDGFRβ, Kit, RET, and Raf-1. This agent is widely used in cancer research for both in vitro mechanistic studies and in vivo xenograft models.
Product Specifications
CAS Number
835621-08-4
Field of Research
Cardiovascular Research, Cell Biology, Pharmacology & Drug Discovery, Signal Transduction
Smiles
CS (O) (=O) =O.CNC (=O) c1cc (Oc2ccc (NC (=O) Nc3ccc (Cl) c (c3) C (F) (F) F) c (F) c2) ccn1
Molecular Formula
C22H19ClF4N4O6S
Molecular Weight
578.92
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
